Pulmonary artery flotation catheter combined with pump-controlled retrograde trial off as a trial for weaning from veno-arterial extracorporeal membrane oxygenation: a case report. (September 2019)

• Record Type: Journal Article
• Authors: Xu, Ying; Gu, Qin
• Is Part Of: Perfusion. Volume 34:Number 6(2019)
• Page Start: 519
• Page End: 522
• Publication Date: 2019-09
• Subjects: veno-arterial extracorporeal membrane oxygenation -- pulmonary artery flotation catheter -- pump-controlled retrograde off -- weaning off; Perfusion (Physiology) -- Periodicals; Blood -- Circulation, Artificial -- Periodicals; Heart -- Surgery -- Periodicals; Extracorporeal Circulation -- Periodicals; Perfusion -- Periodicals; Circulation extracorporelle -- Périodiques; Perfusion -- Périodiques; 617.41
• DOI: 10.1177/0267659118824219
• Languages: English
• ISSNs: 0267-6591

Abstract

Background: The Swan–Ganz catheter is a reliable method used to monitor hemodynamics in intensive care units. Pump-controlled retrograde trial off is a new weaning test for veno-arterial extracorporeal membrane oxygenation in recent years. The objective of this report is to describe a case in which pulmonary artery flotation catheter hemodynamic monitoring in combination with pump-controlled retrograde trial off was sufficient for veno-arterial extracorporeal membrane oxygenation weaning. Methods: We report the case of an adolescent patient with acute heart failure due to acute severe myocarditis in veno-arterial extracorporeal membrane oxygenation, intra-aortic balloon pump, and pulmonary artery flotation catheter hemodynamic monitoring. Results: Pulmonary artery flotation catheter hemodynamic monitoring pre- and post pump-controlled retrograde trial off was successfully proven to predict decannulation success. The patient was weaned off of the extracorporeal membrane oxygenation, intra-aortic balloon pump, and pulmonary artery flotation catheter. His cardiac function gradually recovered, and he was discharged. Conclusion: The combination of pulmonary artery flotation catheter hemodynamic monitoring and pump-controlled retrograde trial off can increase the possibility of veno-arterial extracorporeal membrane oxygenation successful decannulation.